Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Baltimore Harborplace Hotel

Oct 16, 2023 7:30 AM - Oct 17, 2023 6:30 PM

202 E Pratt Street, Baltimore, MD 21202, USA

Real-World Evidence Conference

Translating Insights into Real-World Value

Session 9: Special Populations’ Perspectives on RWD and RWE

Session Chair(s)

Rachele  Hendricks-Sturrup, DrSc, MA, MSc

Rachele Hendricks-Sturrup, DrSc, MA, MSc

Research Director, Real-World Evidence

Duke-Robert J. Margolis, MD, Center for Health Policy, United States

Real-world data is of increasing interest and utility to medical product regulators seeking to observe and monitor treatment outcomes among patients in the real world. This is especially given that clinical trial settings are least reflective of typical settings in which clinically and socio-demographically diverse patients are monitored and treated. In addition, patients with rare diseases must often rely on real-world data to supplement, inform, or drive clinical trials with potential to substantiate timely and potentially life-saving therapies. This session will describe how real-world data is used by regulators to inform clinical trials and post-market strategies, generate insights around social determinants of health, and monitor outcomes in rare disease patients and populations underrepresented in clinical trials.

Learning Objective :
  • Describe how real-world data is used to generate insights about social determinants of health and inform clinical trial and post-market strategies
  • Discuss regulatory uses of real-world data to observe and monitor outcomes in populations that are underrepresented in clinical trials but commonly treated in the real world
  • Demonstrate uses of real-world data sources reflective of and to serve rare disease populations


Jennifer  Lamppa, PhD

RWD and SDOH Generating Insights from Clinical Trials to Post Market Strategies

Jennifer Lamppa, PhD

Inovalon, United States

Associate Vice President, Clinical Analytics

Victoria  Hodgkinson, PhD

Optimizing Real-World Evidence in Rare Disease Registries

Victoria Hodgkinson, PhD

Lumiio Inc., Canada

Chief Scientific Officer

Elizabeth  Packnett, MPH

Regulatory Use of Real-World Data: Quantifying Drug Exposure Risk in Pregnancy with Retrospective Administrative Claims Data

Elizabeth Packnett, MPH

Merative, United States

Lead Researcher, Real World Data Research & Analytics

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.